Bristol-Myers Squibb As of October 10, 2023 ticker dps (an.) 2024 hike 2023 hike 2022 hike
BMY $2.28 0.0% 5.6% 10.2%
Business yield Hike yrs 5 yr CAGR freq. paid since
Pharmaceuticals 4.0% 15 7.3% Quarter 1933

Bristol-Myers Squibb Company (BMY) will raise its quarterly dividend by 2.6 percent to $0.39 per share. This marks the 9th consecutive year of dividend increases by BMY.

The next quarterly dividend will be payable on February 1, 2017, to stockholders of record at the close of business on January 6, 2017.

Today’s dividend increase indicates an annualized rate of $1.56 per common share and a yield of approximately 2.8% based on the $55.23 closing price on December 8, 2016.

Bristol-Myers Squibb Company is is a global specialty biopharmaceutical company.  Bristol-Myers is developing new medicines in the following core therapeutic areas: oncology with a priority in certain tumor types; immunoscience with priorities in psoriasis, lupus, RA and inflammatory bowel disease;  cardiovascular with a priority in heart disease and; fibrotic disease with priorities in lung and liver. The company's top drugs include Opdivo (infused biologic immuno-oncology treatment) and Eliquis (anticoagulation).